会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 35. 发明授权
    • Three-dimensional display article
    • 三维显示文章
    • US08525954B2
    • 2013-09-03
    • US11768937
    • 2007-06-27
    • Yun LiJie LiuGautam ParthasarathyAnping ZhangGelu Comanescu
    • Yun LiJie LiuGautam ParthasarathyAnping ZhangGelu Comanescu
    • G02F1/1347
    • H01L27/3209H01L27/3232H01L2251/5323H04N13/324H04N13/395
    • An article is provided in one embodiment of the invention. The article includes a display structure having a height, a width, and a thickness that define a volume. The display structure further includes components that emit light to generate a three-dimensional image within the volume. The display structure includes a stack. The stack includes at least one layer. The layer includes a substrate, the components that emit light and a controller. The components that emit light may each be secured to the substrate. The controller may be secured to the substrate. The controller may control the components that emit light to generate a three-dimensional image within the volume. The controller may be connected to two or more of the organic electronic devices. The components that emit light may include organic electronic devices. The components that emit light may include a light-emitting nano-wire device. The layer may include at least one sub-layer capable of emitting red light, at least one sub-layer capable of emitting blue light, and at least one sub-layer capable of emitting green light, and at least one layer that is capable of reversibly opacifying.
    • 在本发明的一个实施例中提供了一种物品。 该物品包括具有限定体积的高度,宽度和厚度的显示结构。 显示结构还包括发射光以在该体积内产生三维图像的组件。 显示结构包括堆叠。 堆叠包括至少一层。 该层包括基底,发光的部件和控制器。 发光的部件可以各自固定到基板上。 控制器可以固定到基板。 控制器可以控制发光的部件以在该体积内产生三维图像。 控制器可以连接到两个或更多个有机电子设备。 发光的部件可以包括有机电子器件。 发光的部件可以包括发光纳米线器件。 该层可以包括能够发射红光的至少一个子层,能够发射蓝光的至少一个子层和能够发出绿光的至少一个子层,以及至少一个能够发射绿光的子层 可逆的不透明
    • 37. 发明申请
    • OPTICAL ELEMENT AND LIGHT SOURCE COMPRISING THE SAME
    • 光学元件和包含该光学元件的光源
    • US20110273900A1
    • 2011-11-10
    • US13143608
    • 2010-01-05
    • Yun LiYe Liu
    • Yun LiYe Liu
    • H01L33/02
    • G02B19/0061F21K9/232F21K9/61F21V3/04F21Y2115/10G02B19/0019G02B19/0071
    • The present invention relates to an optical element including a light guide, into which light from one or more light-emitting diodes in a light unit arranged at one end of the light guide is injected, and a reflector arranged at the other end of the light guide capable of reflecting light incident on the reflector. The light guide further includes a prismatic surface comprising a plurality of prisms, each prism being arranged at an angle to an axial direction of the light guide, for guiding the light emitted from the light unit towards the output end of the light guide. The present invention also relates to a light source including an optical element according to the present invention, the light source being arranged for retrofitting into a luminaire employing an incandescent light source.
    • 光学元件技术领域本发明涉及一种光学元件,该光学元件包括导光体,其中布置在光导的一端处的光单元中的一个或多个发光二极管的光注入到该光学元件中,并且布置在该光的另一端的反射器 引导件能够反射入射在反射器上的光。 光导还包括棱镜表面,其包括多个棱镜,每个棱镜以与光导的轴向成一定角度的方式布置,用于将从光单元射出的光导向光导的输出端。 本发明还涉及一种包括根据本发明的光学元件的光源,该光源被布置成用于改装为采用白炽光源的照明器。
    • 38. 发明申请
    • NOVEL STEROID 5-ALPHA-REDUCTASE
    • 新型甾体5-ALPHA-REDUCTASE
    • US20090246785A1
    • 2009-10-01
    • US12404590
    • 2009-03-16
    • James L. MohlerMark TitusOlga KozyrevaO. Harris Ford, IIIElsbieta KawinskiYun Li
    • James L. MohlerMark TitusOlga KozyrevaO. Harris Ford, IIIElsbieta KawinskiYun Li
    • C12Q1/68C12Q1/26
    • C12Q1/26C07K2319/21C07K2319/40C12N9/001C12N2799/022G01N33/57434
    • The invention provides an isolated, novel steroid 5α-reductase enzyme termed SRD5AIII. The protein has an estimated molecular weight of 37 kDa and is capable of converting testosterone to dihydrotestosterone at a pH of about 7.0. Also provided is a method for identifying inhibitors of SRD5AIII by contacting SRD5AIII with a test compound and measuring the activity of the enzyme. A reduced activity relative to a control indicates that the test compound is an inhibitor of SRD5AIII. A method is also provided for detecting androgen stimulated prostate cancer or recurrent prostate cancer in an individual. The method comprises obtaining a prostate biopsy from an individual and determining the level of expression of SRD5AIII gene or protein relative to a normal control. An increased expression of SRD5AIII relative to the control is indicative of androgen stimulated prostate cancer or recurrent prostate cancer.
    • 本发明提供了一种分离的新型类固醇5α-还原酶,称为SRD5AIII。 蛋白质具有37kDa的估计分子量,并且能够在约7.0的pH下将睾酮转化为二氢睾酮。 还提供了通过使SRD5AIII与测试化合物接触并测量酶的活性来鉴定SRD5AIII的抑制剂的方法。 相对于对照的降低的活性表明测试化合物是SRD5AIII的抑制剂。 还提供了用于检测个体中激素刺激的前列腺癌或复发性前列腺癌的方法。 该方法包括从个体获得前列腺活检,并确定相对于正常对照的SRD5AIII基因或蛋白质的表达水平。 SRD5AIII相对于对照的增加的表达指示雄激素刺激的前列腺癌或复发性前列腺癌。
    • 39. 发明申请
    • HIV VACCINE
    • 艾滋病疫苗
    • US20090175889A1
    • 2009-07-09
    • US12201014
    • 2008-08-29
    • Shiu-Lok HuYun LiBradley Cleveland
    • Shiu-Lok HuYun LiBradley Cleveland
    • A61K39/21C12N15/11C12N7/00C07K14/00C12N5/06A61K31/7088
    • A61K39/21A61K39/12A61K2039/5154A61K2039/53A61K2039/545A61K2039/55505C07K14/005C12N15/86C12N2710/24143C12N2740/15034C12N2740/16134C12N2740/16222
    • The invention provides a polynucleotide encoding an envelope protein comprising gp120 of human immunodeficiency virus-1 (HIV-1) having a mutation at amino acid residues 197-199 whereby a single N-linked glycan is removed. In a typical embodiment, the mutation replaces the asparagine (N) at residue 197 with another amino acid, such as glutamine (Q), creating an N197Q mutation. Because the N197 glycan is highly conserved among HIV-1 subtypes, this approach is applicable across HIV-1 isolates. The invention provides polypeptides, polynucleotides encoding the polypeptides, vectors, and recombinant viruses containing the polynucleotides, antigen-presenting cells (APCs) presenting the polypeptides, immune cells directed against HIV, and pharmaceutical compositions. The invention additionally provides methods, including methods for preventing and treating infection, for killing infected cells, for inhibiting viral replication, for enhancing secretion of antiviral and/or immunomodulatory lymphokines, and for enhancing production of neutralizing antibody.
    • 本发明提供了编码包含蛋白质的多核苷酸,其包含在氨基酸残基197-199上具有突变的人免疫缺陷病毒-1(HIV-1)的gp120,由此除去单个N-连接的聚糖。 在典型的实施方案中,突变将残基197处的天冬酰胺(N)替换为另外的氨基酸,例如谷氨酰胺(Q),产生N197Q突变。 因为N197聚糖在HIV-1亚型中是高度保守的,所以这种方法适用于HIV-1分离株。 本发明提供了多肽,编码多肽的多核苷酸,载体和含有多核苷酸的重组病毒,呈递多肽的抗原呈递细胞(APC),针对HIV的免疫细胞和药物组合物。 本发明还提供方法,包括用于预防和治疗感染的方法,用于杀死感染的细胞,用于抑制病毒复制,增强抗病毒和/或免疫调节淋巴因子的分泌,以及增强中和抗体的产生。